Fieldpoint Private Securities’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$57K Sell
1,242
-42
-3% -$1.88K 0.02% 457
2022
Q1
$60K Buy
1,284
+141
+12% +$6.31K 0.01% 539
2021
Q4
$57K Buy
1,143
+35
+3% +$1.81K 0.01% 570
2021
Q3
$59K Buy
1,108
+3
+0.3% +$169 0.01% 535
2021
Q2
$63K Sell
1,105
-122
-10% -$6.48K 0.01% 521
2021
Q1
$60K Buy
1,227
+333
+37% +$15.6K 0.01% 526
2020
Q4
$36K Buy
+894
New +$32K 0.01% 532
2020
Q1
Sell
-1,145
Closed -$41K 430
2019
Q4
$41K Buy
1,145
+502
+78% +$17.3K 0.01% 469
2019
Q3
$22K Buy
643
+425
+195% +$13.6K 0.01% 508
2019
Q2
$6K Buy
+218
New +$6.06K ﹤0.01% 672

Other funds holding LMAT

Fieldpoint Private Securities's LMAT Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its LeMaitre Vascular (LMAT) stake by 3.3% in Q2 2022, selling an estimated $1.88K and leaving 1,242 shares worth $57K. The position accounts for 0.02% of the portfolio, ranked #457.

Fieldpoint Private Securities first reported a position in LMAT in Q2 2019 and has held it in 10 quarters since. The position peaked at $63K in Q2 2021. 178 funds tracked by Wall St. Rank hold LMAT as of Q2 2022.

  • Fieldpoint Private Securities held 1,242 shares of LeMaitre Vascular worth $57K as of Q2 2022.
  • Fieldpoint Private Securities sold 42 LeMaitre Vascular shares in Q2 2022, an estimated $1.88K.
  • LeMaitre Vascular made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #457 holding.
  • Fieldpoint Private Securities first reported a position in LeMaitre Vascular in Q2 2019 and has held it in 10 quarters since.
  • Fieldpoint Private Securities's LeMaitre Vascular position peaked at $63K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.